Short-term Clinical Experience on Interferon gamma-1b Therapy for Idiopathic Pulmonary Fibrosis
![]() ![]() |
Hwang, Jung Hye
(Division of Pulmonary and Critical Care Medicine, Department of Medicine, Sungkyunkwan University School of Medicine)
Chung, Man Pyo (Division of Pulmonary and Critical Care Medicine, Department of Medicine, Sungkyunkwan University School of Medicine) Kang, Eun Hae (Division of Pulmonary and Critical Care Medicine, Department of Medicine, Sungkyunkwan University School of Medicine) Kim, Kyung Chan (Division of Pulmonary and Critical Care Medicine, Department of Medicine, Sungkyunkwan University School of Medicine) Lee, Byoung-Hoon (Division of Pulmonary and Critical Care Medicine, Department of Medicine, Sungkyunkwan University School of Medicine) Koh, Won-Jung (Division of Pulmonary and Critical Care Medicine, Department of Medicine, Sungkyunkwan University School of Medicine) Suh, Gee Young (Division of Pulmonary and Critical Care Medicine, Department of Medicine, Sungkyunkwan University School of Medicine) Kim, Hojoong (Division of Pulmonary and Critical Care Medicine, Department of Medicine, Sungkyunkwan University School of Medicine) Lee, Kyung Soo (Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Han, Joungho (Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kwon, O Jung (Division of Pulmonary and Critical Care Medicine, Department of Medicine, Sungkyunkwan University School of Medicine) |
1 | Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovector-mediated gene transfer of active transforming growth factorbeta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997;100:768-76 |
2 | Honore I, Nunes H, Groussard O, Kambouchner M, Chambellan A, Aubier M, et al. Acute respiratory failure after interferongamma therapy of end-stage pulmonary fibrosis. Am J Respir Crit Care Med 2003; 167:953-7 |
3 | Kolb M, Kirschner J, Riedel W, Wirtz H, Schmidt M. Cyclophosphamide pulse therapy in idiopathic pulmonary fibrosis. Eur Respir J 1998;12:1409-14 |
4 | Specks U, Nerlich A, Colby TV, Wiest I, Timpl R. Increased expression of type VI collagen in lung fibrosis. Am J Respir Crit Care Med 1995;151:1956-64 |
5 | Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH. A preliminary study of longterm treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999;341:1264-9 |
6 | Mason RJ, Schwarz MI, Hunninghake GW, Musson RA. NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future. Am J Respir Crit Care Med 1999;160:1771-7 |
7 | Elias JA, Freundlich B, Kern JA, Rosenbloom J. Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest 1990;97:1439-45 |
8 | Muller NL, Mawson JB, Mathieson JR, Ab boud R, Ostrow DN, Champion P. Sar coidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings. Radiology 1989;171:613-8 |
9 | American Thoracic Society. Idiopathic pulmonary Fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-64 |
10 | Dayton CS, Schwartz DA, Helmers RA, Pueringer RJ, Gilbert SR, Merchant RK, et al. Outcome of subjects with idiopathic pulmonary fibrosis who fail corticosteroid therapy. Implications for further studies. Chest 1993;103:69-73 |
11 | Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-51 |
12 | Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001; 345:517-25 |
13 | Antoniou KM, Polychronopoulos V, Dimadi M, Rapti A, Lambrakis C, Lasti P, et al. Comparison of Interferon Gamma-1b and Colchicine in the Treatment of Idiopathic Pulmonary Fibrosis: Interim Results of a Prospective, Multicenter Randomized Study. Am J Respir Crit Care Med 2003;167(7) A168 |
14 | Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-15 |
15 |
Fishman AP. Fishman’s Pulmonary Disease and Disorders |
16 | Zisman DA, Lynch JP 3rd, Toews GB, Kazerooni EA, Flint A, Martinez FJ. Cyclo phosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to cortico steroids. Chest 2000;117:1619-26 |
17 | 전경만, 정만표, 신성철, 유창민, 고원중, 서지영, 등. 통상성 간질성 폐렴과 비특이성 간질성 폐렴의 치료에 있어 Cyclophosphamide의 역할. 결핵 및 호흡기질환 2003;55:175-87 |
18 | Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;350:125-3 |
19 | Ryu JH, Colby TV, Hartman TE. Idiopathic pulmonary fibrosis: current concepts. Mayo Clin Proc 1998;73:1085-101 |
![]() |